Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-26-140126
Filing Date
2026-04-02
Accepted
2026-04-02 16:14:08
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A repligen_-_defa14a_-_202.htm DEFA14A 22648
2 GRAPHIC img81011626_0.jpg GRAPHIC 294507
3 GRAPHIC img81011626_1.jpg GRAPHIC 192763
  Complete submission text file 0001193125-26-140126.txt   695038
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

EIN.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-14656 | Film No.: 26833640
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)